150 related articles for article (PubMed ID: 31407729)
21. Improved gastrointestinal stability of solid lipid nanoparticles using comb-shaped amphiphilic inulin derivatives.
Peng T; Guo F; Liang D; Gao Y; Zhang X; Qiu S; Liu J; Zhong H
Pharmazie; 2019 Jan; 74(1):47-53. PubMed ID: 30782250
[TBL] [Abstract][Full Text] [Related]
22. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.
Qi J; Lu Y; Wu W
Curr Drug Metab; 2012 May; 13(4):418-28. PubMed ID: 22443536
[TBL] [Abstract][Full Text] [Related]
23. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.
Harde H; Das M; Jain S
Expert Opin Drug Deliv; 2011 Nov; 8(11):1407-24. PubMed ID: 21831007
[TBL] [Abstract][Full Text] [Related]
24. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice.
Xue M; Zhang L; Yang MX; Zhang W; Li XM; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2015; 10():5049-57. PubMed ID: 26346310
[TBL] [Abstract][Full Text] [Related]
25. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability.
Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y
Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336
[TBL] [Abstract][Full Text] [Related]
26. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
27. PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study.
Arduino I; Depalo N; Re F; Dal Magro R; Panniello A; Margiotta N; Fanizza E; Lopalco A; Laquintana V; Cutrignelli A; Lopedota AA; Franco M; Denora N
Int J Pharm; 2020 Jun; 583():119351. PubMed ID: 32339634
[TBL] [Abstract][Full Text] [Related]
28. Control of the gastrointestinal digestion of solid lipid nanoparticles using PEGylated emulsifiers.
Ban C; Jo M; Lim S; Choi YJ
Food Chem; 2018 Jan; 239():442-452. PubMed ID: 28873589
[TBL] [Abstract][Full Text] [Related]
29. Fenofibrate oral absorption from SNEDDS and super-SNEDDS is not significantly affected by lipase inhibition in rats.
Michaelsen MH; Siqueira Jørgensen SD; Abdi IM; Wasan KM; Rades T; Müllertz A
Eur J Pharm Biopharm; 2019 Sep; 142():258-264. PubMed ID: 31276759
[TBL] [Abstract][Full Text] [Related]
30. Formulation, optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis.
Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Dec; 44(12):1975-1989. PubMed ID: 30058392
[TBL] [Abstract][Full Text] [Related]
31. Solid lipid nanoparticles for enhanced oral absorption: A review.
Salah E; Abouelfetouh MM; Pan Y; Chen D; Xie S
Colloids Surf B Biointerfaces; 2020 Dec; 196():111305. PubMed ID: 32795844
[TBL] [Abstract][Full Text] [Related]
32. Effects of PEGylated lipid nanoparticles on the oral absorption of one BCS II drug: a mechanistic investigation.
Zhang X; Chen G; Zhang T; Ma Z; Wu B
Int J Nanomedicine; 2014; 9():5503-14. PubMed ID: 25473287
[TBL] [Abstract][Full Text] [Related]
33. In vivo fate of lipid-based nanoparticles.
Qi J; Zhuang J; Lu Y; Dong X; Zhao W; Wu W
Drug Discov Today; 2017 Jan; 22(1):166-172. PubMed ID: 27713035
[TBL] [Abstract][Full Text] [Related]
34. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration.
Shah MK; Madan P; Lin S
Pharm Dev Technol; 2014 Jun; 19(4):475-85. PubMed ID: 23697916
[TBL] [Abstract][Full Text] [Related]
35. [Polyelectrolyte layer-by-layer assembled lipid nanoparticles for improving oral absorption of doxorubicin].
Shen AJ; Xia DN; Gan Y; Li J
Yao Xue Xue Bao; 2016 Jul; 51(7):1136-43. PubMed ID: 29897223
[TBL] [Abstract][Full Text] [Related]
36. The lipid type affects the in vitro digestibility and β-carotene bioaccessibility of liquid or solid lipid nanoparticles.
Helena de Abreu-Martins H; Artiga-Artigas M; Hilsdorf Piccoli R; Martín-Belloso O; Salvia-Trujillo L
Food Chem; 2020 May; 311():126024. PubMed ID: 31855778
[TBL] [Abstract][Full Text] [Related]
37. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
39. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
40. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]